Cannabis Law Report

JULY 25, 2022

Conversation Tackles MAPS Research Methadology & Issues Of Abuse In Therapy. Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. They receive MMI’s Certificate of Psychedelic Assisted Therapy.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. I am also prescribed pharmacological and non-pharmacological therapies and try to keep a base of exercise and good nutrition. Patient advocacy is alive and well in Canada. This is what it means to be Canadian to me.

Access 45

Access Patients Marijuana Medicine 45

Leaf Science

JUNE 28, 2019

Abruptly woken from their sleep, a very young Steve DeAngelo and his brothers were hastily ushered into the family car and driven away at speed. I found couches to sleep on but I realized very quickly that it was not sustainable”. A place where not only cannabis is sold but alternative therapies are performed also!

Decriminalization 64

Decriminalization Sleep Access Law 64

The Cannigma

DECEMBER 12, 2022

The results are so compelling that the FDA has categorized magic mushrooms as a “breakthrough therapy” for depression, and is committed to fast tracking its approval. Stage three lasts up to 72 hours after ingestion, and is characterized by mild stimulation, heightened awareness and disrupted sleep. 19 20 21 22 23.

History 123

History Microdosing Research and Development Clinical Trials 123

Cannabis Law Report

NOVEMBER 24, 2021

Media representations can offer insights into the nature of the discourse about new medical products and therapies and how ideas and understandings about social phenomena become constructed. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. Conditions most frequently mentioned.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

FEBRUARY 16, 2022

We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. Is this as needed for sleep? They’re college athletes, or they’re not sleeping, their bodies aren’t recovering. EG: All right, so that’s going to be straight up to the interview.

Trichome 78

Trichome Wellness and Beauty Cannabinoids Cannabis 78

The Cannigma

JANUARY 19, 2022

Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. I mean, asking questions was like, how can I function, how can I sleep, how can I not be in pain.

Patients 87

Patients Compliance Compliance Cannabis 87

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. In 2018, it led to ketamine therapy, and it’s still changing his life. Truffles Therapy. Drug Science. Matthew Johnson.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 30, 2019

Even with all the past federal missteps and current obstacles, these determined medics want to help keep patients healthier and safer with natural, plant-derived medicine, rather than the more synthetic pharmaceutical alternatives that can prove to be even riskier therapies with highly addictive propensities. .

Marijuana 45

Marijuana Patients Research and Development Programs 45